Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will
Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will have an important role in imaging and medicine, and the new name better captures this movement.
Systems using OCT have already been deployed for use in ophthalmic applications (SCAN 9/1/99). The FDA is reviewing several LightLab Imaging products using OCT for market clearance. In addition, the company has products in the pipeline that it will submit to the FDA in the near future, according to a company spokesperson.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.